Oct
30
Archive for October, 2007
Oct
30
Sunlight may cut breast cancer risk for some women
Exposure to sunlight may reduce the risk of advanced breast cancer
in women with light skin pigmentation, according to the results of
a population-based study appearing in the American Journal of
Epidemiology.
Oct
30
Folic acid use declines in some Californian women
New data from the California Women’s Health Survey suggest that the
use of folic acid supplements is declining among Hispanic women and
among less educated women in the state.
Oct
30
Cholesterol drug may improve prostate cancer
Treatment with statins, a widely used class of cholesterol-lowering
drugs, which include Lipitor, Crestor and Zocor, is associated with
a longer rate of relapse-free survival after radiotherapy for
prostate cancer, particularly among patients with more aggressive
cancers, researchers reported here at the annual meeting of the
American Society for Therapeutic Radiology and Oncology (ASTRO).
Oct
30
Echinacea may boost post-workout immunity
The popular herbal remedy echinacea may give the immune system a
lift after an intense workout, and possibly make exercisers’ colds
a little easier to take, a study suggests.
Oct
30
Zinc Helps Elderly Ward Off Pneumonia
Nursing home study finds it can prevent or shorten the illness
Oct
30
Stretching may offer extended benefits
If stretching ranks below turning down the volume on your iPod on your list of health priorities, a new report may give you extra incentive to reach, bend and twist.
Oct
30
Looking at Dutch and Swiss Health Systems
The Swiss and Dutch health care systems are suddenly all the rage, and next month the United States’ top health official will visit Switzerland and the Netherlands to kick the tires.
Oct
30
Low Buzz May Give Mice Better Bones and Less Fat
New research suggests that in mice, a simple treatment that does not involve drugs appears to be directing cells to turn into bone instead of fat.
Oct
30
Participants Left Uninformed in Some Halted Medical Trials
Drug and medical device makers will not be forced to disclose the results of clinical trials on some products that never reached the marketplace.